Effects of the Endothelin Receptor Antagonist Bosentan on Hemodynamics, Symptoms and Functional Capacity in Japanese Patients With Severe Pulmonary Hypertension-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Effects of the Endothelin Receptor Antagonist Bosentan on Hemodynamics, Symptoms and Functional Capacity in Japanese Patients With Severe Pulmonary Hypertension

Published:2005 Issue:2 Volume:69 Page:131-137
ISSN:1346-9843
Container-title:Circulation Journal
language:en
Short-container-title:Circ J

Author:

Sasayama Shigetake¹,Kunieda Takeyoshi²,Tomoike Hitonobu³,Matsuzaki Masunori⁴,Shirato Kunio⁵,Kuriyama Takayuki⁶,Izumi Tohru⁷,Origasa Hideki⁸,Giersbergen Paul LM van⁹,Dingemanse Jasper⁹,Tanaka Satoshi⁹

Affiliation:

1. Hamamatsu Rosai Hospital

2. Ise Keio Hospital

3. National Cardiovasular Center

4. Yamaguchi University Graduate School of Medicine

5. Tohoku University Graduate School of Medicine

6. Chiba University Graduate School of Medicine

7. Kitasato University School of Medicine

8. Toyama Medical and Pharmaceutical University

9. Actelion Pharmaceuticals Ltd

Publisher

Japanese Circulation Society

Subject

Cardiology and Cardiovascular Medicine,General Medicine

Link

http://www.jstage.jst.go.jp/article/circj/69/2/69_2_131/_pdf

Reference34 articles.

1. Primary Pulmonary Hypertension

2. Primary Pulmonary Hypertension

3. RISK FACTORS FOR PULMONARY ARTERIAL HYPERTENSION

4. A Comparison of Continuous Intravenous Epoprostenol (Prostacyclin) with Conventional Therapy for Primary Pulmonary Hypertension

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Contribution of pressure and flow changes to resistance reduction after pulmonary arterial hypertension treatment: a meta-analysis of 3898 patients;ERJ Open Research;2023-12-07

2. Goal-Oriented Sequential Combination Therapy Evaluated Using Cardiopulmonary Exercise Parameters for the Treatment of Newly Diagnosed Pulmonary Arterial Hypertension　― Goal-Oriented Therapy Evaluated by Cardiopulmonary Exercise Testing for Pulmonary Arterial Hypertension (GOOD EYE) ―;Circulation Reports;2019-07-10

3. Clinical Use of Pediatric Bosentan in Japanese Children with Pulmonary Arterial Hypertension: Investigation of Efficacy, Pharmacokinetics, Safety, and Tolerability;Pediatric Cardiology and Cardiac Surgery;2018

4. Surveillance on The Safety and Efficacy of Ambrisentan (Volibris Tablet 2.5 mg) in Patients with Pulmonary Arterial Hypertension in Real Clinical Practice: Post-marketing Surveillance (Interim Analysis Report);Clinical Drug Investigation;2017-12-27

5. Bosentan and Rifampin Interactions Modulate Influx Transporter and Cytochrome P450 Expression and Activities in Primary Human Hepatocytes;Biomolecules & Therapeutics;2017-05-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3